Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IRB, HIPAA Changes To Be Folded Into 21st Century Cures Bill Next Year

This article was originally published in The Gray Sheet

Executive Summary

Centralized institutional review board approvals for device trials, and removal of HIPAA privacy provisions that block registry data-sharing are among the ideas that are likely to make it into a draft bill planned for release in January as the next step in the House’s 21st Century Cures initiative.

You may also be interested in...



Party Leaders, Former St. Jude Exec Lead In Medtech Campaign Donations

For the 2015-2016 congressional campaign election cycle, House and Senate party leaders, as well as incumbents sponsoring industry-supported bills, are attracting significant donations. But one of industry's own, former St Jude Medical employee Angie Craig, is making a run as a Democrat for a House seat in Minnesota's 2nd congressional district. She has received the most donations from industry, in particular from her former St Jude colleagues, campaign funding data compiled by The Gray Sheet shows.

Senate Bill Tackles 'Least Burdensome,' Centralized IRBs, CLIA Waivers

The targeted FDA Device Accountability Act mirrors select device sections of the House 21st Century Cures legislation seeking to strengthen the use of "least-burdensome" provisions, allow use of centralized IRBs for device trials and refining standards for diagnostic CLIA waivers.

AdvaMed Innovation Agenda Aligns With Capitol Hill Objectives

A review of the medical device trade group's “Innovation Agenda” for the coming year and the recent 21st Century Cures proposal in Congress suggests a supportive environment for the association's priorities.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT033309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel